203 related articles for article (PubMed ID: 21033475)
1. [Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)].
Goriacheva LG; Romantsov MG; Agaeva SG; Lin'kov IuN; Kovalenko AL
Antibiot Khimioter; 2010; 55(5-6):50-7. PubMed ID: 21033475
[TBL] [Abstract][Full Text] [Related]
2. [Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)].
Sologub TV; Shul'diakov AA; Goriacheva LG; Baranova IP; Lin'kova IuN; Kovalenko AL; Romantsov MG
Antibiot Khimioter; 2010; 55(9-10):37-41. PubMed ID: 21400753
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of immune response to etiotropic and pathogenetic therapy in children with chronic hepatitis C].
Vasil'eva DK; Goriacheva LG; Monakhova NE
Eksp Klin Farmakol; 2011; 74(12):33-5. PubMed ID: 22379880
[TBL] [Abstract][Full Text] [Related]
4. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
[TBL] [Abstract][Full Text] [Related]
5. [Cycloferon therapy of acute and chronic virus hepatitis C].
Malyĭ VP; Pen'kov DV; Chiriukina OI
Antibiot Khimioter; 2013; 58(9-10):34-40. PubMed ID: 24738241
[TBL] [Abstract][Full Text] [Related]
6. [Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis].
Vasil'eva DK; Goriacheva LG; Kotiv MIa; Alekseeva LA; Romantsov MG; Bessonova TV
Antibiot Khimioter; 2011; 56(3-4):46-50. PubMed ID: 21913409
[TBL] [Abstract][Full Text] [Related]
7. [Meglumine acridonacetate in combined antiviral treatment of HBeAg-positive chronic hepatitis B].
Stel'makh VV; Okovityĭ SV; Romantsov MG; Tuan NKh; Oiungerel M
Georgian Med News; 2013 Jun; (219):33-9. PubMed ID: 23863208
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)].
Romantsov MG; Sologub TV; Goriacheva LG; Kovalenko SN; Sukhanov DS; Shul'diakov AA; Bondarenko AN; Kovalenko AL; Petrov AIu
Antibiot Khimioter; 2010; 55(3-4):45-55. PubMed ID: 20695208
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of chronic viral hepatitis].
Pedersen C; Pedersen CR
Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficiency of reamberin - cycloferon combination in treatment of hepatic cirrhosis associated with chronic HCV infection].
Frolov VM; Sotskaia IaA; Kruglova OV
Eksp Klin Farmakol; 2012; 75(8):34-8. PubMed ID: 23012994
[TBL] [Abstract][Full Text] [Related]
11. Use of recombinant alpha-2b-interferon in combination with antioxidants in the form of rectal suppositories (viferon) in children with chronic hepatitides B and C.
Uchaikin V; Cherednichenko T; Malinovskaya V; Orlova T; Kovalev O; Kharlamova F; Chaplygina G; Konev V; Voronina F; Delenian N
Acta Virol; 2000 Apr; 44(2):79-83. PubMed ID: 10989698
[TBL] [Abstract][Full Text] [Related]
12. [Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy].
Romantsov MG; Kovalenko SN; Sologub TV; Anikina OV
Antibiot Khimioter; 2008; 53(3-4):18-22. PubMed ID: 18942421
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hepatitis B and C in children.
El-Shabrawi M; Hassanin F
Minerva Pediatr; 2014 Oct; 66(5):473-89. PubMed ID: 25253190
[TBL] [Abstract][Full Text] [Related]
14. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
Pár A; Tornai I; Szalay F
Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results].
Romantsov MG; Sologub TV; Shul'diakov AA; Goriacheva LG; Lin'kova IuN; Kovalenko AL
Eksp Klin Farmakol; 2010 Nov; 73(11):30-3. PubMed ID: 21254596
[TBL] [Abstract][Full Text] [Related]
16. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses.
Agrawal B; Kumar R
World J Gastroenterol; 2016 Jul; 22(25):5623-6. PubMed ID: 27433078
[TBL] [Abstract][Full Text] [Related]
17. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Yalcin K; Degertekin H; Yildiz F; Kilinc N
J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
[TBL] [Abstract][Full Text] [Related]
19. [Comparative efficacy of etiotropic therapy of patients with HBeAg-positive chronic hepatitis B (by the data of the international comparative placebo-controlled study)].
Stel'makh VV; Romantsov MG; Sologub TV; Shul'diakov AA; Kozlov VK; Tuan NKh; Oyungerel M; Frolov VM
Antibiot Khimioter; 2013; 58(9-10):27-33. PubMed ID: 24738240
[TBL] [Abstract][Full Text] [Related]
20. [Cycloferon: mechanism of action, functions and application].
Bazhanova ED
Eksp Klin Farmakol; 2012; 75(7):40-4. PubMed ID: 23025052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
